NOVEL DOSING REGIMENS OF CELGOSIVIR FOR THE TREATMENT OF DENGUE
摘要
Methods of treating a dengue virus (DENV) infection in a human subject, comprising administering to the human subject a compound of Formula (I), or pharmaceutical composition comprising a compound of Formula (I):A compound of Formula (I) can be administered within onset of fever to 72 hours of fever onset due to dengue infection and then every 6 to12 hours until there is an improvement in the infection or between from about 1 day to about 10 days. The methods of the invention can be used to treat primary and secondary DENV1-4 viral infections.
申请公布号
PH12015502128(A1)
申请公布日期
2016.01.25
申请号
PH12015502128
申请日期
2015.09.15
申请人
NATIONAL UNIVERSITY OF SINGAPORE;60O PHARMACEUTICALS LLC;SINGAPORE HEALTH SERVICES PTE LTD
发明人
VASUDEVAN, SUBHASH;SUNG, CYNTHIA;RATHORE, ABHAY;WATANABE, SATORU;LOW, JENNY;OOI, ENG EONG;DOW, GEOFFREY S.;MORRISH, GLYNN;REID, MARK